Barletta JF - Search Results

1

Barletta JF, Bruno JJ, Buckley MS, Cook DJ. Barletta JF, et al. Crit Care Med. 2016 Jul;44(7):1395-405. doi: 10.1097/CCM.0000000000001872. Crit Care Med. 2016. PMID: 27163192 Review.

2

Stress ulcer prophylaxis in trauma patients.

Barletta JF, Erstad BL, Fortune JB. Barletta JF, et al. Crit Care. 2002 Dec;6(6):526-30. doi: 10.1186/cc1831. Epub 2002 Sep 25. Crit Care. 2002. PMID: 12493075 Free PMC article.

3

High glucose variability increases cerebral infarction in patients with spontaneous subarachnoid hemorrhage.

Barletta JF, Figueroa BE, DeShane R, Blau SA, McAllen KJ. Barletta JF, et al. J Crit Care. 2013 Oct;28(5):798-803. doi: 10.1016/j.jcrc.2012.12.012. Epub 2013 Feb 18. J Crit Care. 2013. PMID: 23428707

4

Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.

Barletta JF, Sclar DA. Barletta JF, et al. Pharmacoeconomics. 2014 Jan;32(1):5-13. doi: 10.1007/s40273-013-0119-5. Pharmacoeconomics. 2014. PMID: 24271943 Review.

5

Off-label use of gastrointestinal medications in the intensive care unit.

Barletta JF, Lat I, Micek ST, Cohen H, Olsen KM, Haas CE; Critical Care Pharmacotherapy Trials Network. Barletta JF, et al. J Intensive Care Med. 2015 May;30(4):217-25. doi: 10.1177/0885066613516574. Epub 2013 Dec 20. J Intensive Care Med. 2015. PMID: 24362446

6

Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock.

Barletta JF. Barletta JF. Ann Pharmacother. 2014 Oct;48(10):1276-81. doi: 10.1177/1060028014540513. Epub 2014 Jun 30. Ann Pharmacother. 2014. PMID: 24982312

7

Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.

Barletta JF, Kanji S, MacLaren R, Lat I, Erstad BL; American-Canadian consortium for Intensive care Drug utilization (ACID) Investigators. Barletta JF, et al. J Crit Care. 2014 Dec;29(6):955-60. doi: 10.1016/j.jcrc.2014.06.025. Epub 2014 Jun 30. J Crit Care. 2014. PMID: 25081626

8

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.

Barletta JF, Sclar DA. Barletta JF, et al. Crit Care. 2014 Dec 24;18(6):714. doi: 10.1186/s13054-014-0714-7. Crit Care. 2014. PMID: 25540023 Free PMC article.

9

Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.

Buckley MS, Park AS, Anderson CS, Barletta JF, Bikin DS, Gerkin RD, O'Malley CW, Wicks LM, Garcia-Orr R, Kane-Gill SL. Buckley MS, et al. Among authors: barletta jf. Am J Med. 2015 Aug;128(8):905-13. doi: 10.1016/j.amjmed.2015.02.014. Epub 2015 Mar 27. Am J Med. 2015. PMID: 25820164

10

Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients.

Buckley MS, Reeves BA, Barletta JF, Bikin DS. Buckley MS, et al. Among authors: barletta jf. Ann Pharmacother. 2016 Apr;50(4):276-81. doi: 10.1177/1060028015627468. Epub 2016 Jan 18. Ann Pharmacother. 2016. PMID: 26783351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page